dc.creatorCano Schuffeneger, Francisco
dc.date.accessioned2019-01-29T17:15:45Z
dc.date.available2019-01-29T17:15:45Z
dc.date.created2019-01-29T17:15:45Z
dc.date.issued1998
dc.identifierRevista Medica de Chile, Volumen 126, Issue 1, 2018, Pages 96-106
dc.identifier00349887
dc.identifierhttps://repositorio.uchile.cl/handle/2250/163322
dc.description.abstractThe rapid advances in immunobiology, pharmacology and molecular biology have made successful renal transplantation the optimal therapeutic modality for adults and children, reaching a near -90% of patient-graft survival among the first years of transplant. But this knowledge also presents clinicians and scientists with difficult challenges, one of the most important remaining is the chronic rejection of the graft. A critical review of the immunobiology, clinical evolution and histopathology of chronic rejection is presented. Immunosuppressive agents with emphasis in their mechanism of action is also detailed.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Medica de Chile
dc.subjectKidney failure, chronic
dc.subjectKidney transplantation
dc.subjectTransplantation immunology
dc.titleRenal transplant and chronic rejection in pediatrics Trasplante renal y rechazo crónico en pediatría
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución